Viewing 0 reply threads
  • Author
    Posts
    • #19289
      Michael Morale
      Keymaster
      Monday, June 3, Through Sunday, June 9 – With last week being as busy as it was, this week, was the complete opposite. Other than my daily work for BioNews Services, the only time that I left the house was when I went for my workout with Emily. Other than that, I’ve been secluded in my home office, with the door shut recording flash briefings and podcasts. I can actually say for the first time in a long time, that I miss human interaction. It’s funny how fast the week went, because spending days recording articles that are newsworthy along with editing these files and putting everything together, takes quite a bit of time, and this time went much faster than I thought it would.
       
      This past week, when I went for my workout with Emily, we did my 4 week reevaluation. Emily took all of the measurements that we needed for this reevaluation in about 30 minutes, so we had the remainder of the hour to work on core strengthening. Overall, my reevaluation went very well. I posted my reevaluation results for the past 2 months on my website.
      The part of the reevaluation that excites me the most is how much I’m able to stretch my legs out. When I first started, my right leg had over a -40° bend. Now, my right leg is it -19°, and my left leg is it -21°. This is quite an improvement since I began. The rotation in my neck seems to be better, and I’m able to look further to my left and to my right. Even though these numbers may not change dramatically from week to week, these are not necessarily meant to be dramatic changes. Most people with SMA get weaker as they get older, and with getting weaker, they lose the ability to rotate their neck and to function as they used to. The purpose of these exercises we go through are meant to maintain my numbers and to possibly improve. As I said, my numbers may not be getting dramatically better, but they are at least improving and slow increments. Click HERE to view my test results.
      Next week, when I go for my workout with Emily, she and Vicki will transfer me from my wheelchair to the therapy table and we will do the range of motion and flexing exercises on my hips, legs, knees, ankles and feet. While I enjoyed every aspect of my physical therapy, transferring to the therapy table is the part of my therapy that I really enjoy the most. Next week, instead of me just sitting on the cushion on the therapy table and having Emily push me forward, backwards and from side to side, she’s going to begin using the yellow resistance band so that we can do more isometric exercises to improve my balance. While sitting on the cushion on the therapy table, Emily will stand behind me and put the yellow resistance band around my chest. She will then slowly begin pulling me backwards, and my job will be to maintain my balance and stay in a neutral sitting position. Emily will also stand in front of me and put the yellow resistance band around my back, and pull me forward toward her. Again, my job will be to remain in an upright neutral sitting position.
      While this sounds easy, it doesn’t take a lot to throw my balance off while I’m sitting on this cushion, so I know that these exercises are going to provide a great challenge along with a great workout on my core muscles. I actually made the suggestion to Emily a few weeks ago, and she said that this would really be a great challenge for me. As my balance and my core strength improves, we will move from the yellow resistance band, the one that has the least amount resistance, to the other colored resistance bands that provide a greater amount of resistance. While this may take some time, I can truly see benefits with my balance and my core strength, so I’m looking forward to this new exercise.
       
      In this week’s video, I go over the key differences between AveXis’s treatment known as ZOLGENSMA, and Biogen’s treatment known as Spinraza. Surprisingly, there are quite a few differences between these treatments and how they react in our bodies. While ZOLGENSMA was the 2nd FDA approved treatment for SMA, it’s actually the first gene therapy that has the FDA stamp of approval. These 2 treatments give those of us with SMA a great deal of hope for our future. In the description of my video, I provide a link to a YouTube video that I found nearly a year ago that goes into great detail regarding how Spinraza repairs the SMN2 gene. This is a fascinating video that I think all of you will enjoy watching. Click HERE to view that video.
      I also provide 2 other links from articles that BioNews Services wrote regarding the FDA approval of ZOLGENSMA, and another article that discusses what ZOLGENSMA does in our bodies. Click HERE to view the article regarding the FDA announcement, and click HERE to view the video that discusses how ZOLGENSMA works. Click HERE to view my weekly video. The next therapy coming down the pipeline is Risdiplam, and I’m going to go into great detail regarding this potential treatment in the next few weeks. While there may not be a possibility of a combination therapy between ZOLGENSMA and Spinraza, the likelihood of a combination therapy between Spinraza and Risdiplam may be something that we can look forward to. Risdiplam, like Spinraza, works on the SMN2 gene, and there is quite a bit of talk around the grapevine regarding these 2 therapies working together to provide benefits for those of us with SMA.
       
      I’ve updated the flash briefings that I do for BioNews Services. Click HERE to go the flash briefings.
       
      I hope that all of you had a fantastic week. Do something for yourself this upcoming week that will make you a better person. God bless you and I’ll see you soon.
Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2022 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

or    

Forgot your details?

Create Account